Meditrina Pharmaceuticals
Ann Arbor
About Meditrina Pharmaceuticals
Meditrina Pharmaceuticals, Inc. identifies and repurposes already marketed therapies and product candidates at advanced stages of development for new indications focused on improving women’s health disorders with unmet medical needs. The Company’s initial focus is in overlooked therapeutic areas that affect millions of women each year. These areas include gynecologic and aromatase-meditated conditions such as endometriosis and uterine fibroids.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.5M
- Funding stage: Early Stage Venture
- Last round: Debt Financing (Dec 2010)
- Website: meditrina.com
- Phone: +1 734-926-0966
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/meditrina-pharmaceuticals-2416912 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.